Medtech InsightRoss Segan Named OPEQ Director Ross Segan is the new head of the Office of Product Evaluation and Quality (OPEQ) in the US Food and Drug Administration’s Center for Devices and Radiological Health, th
Medtech InsightIV BioHoldings launched three liquid biopsy start-ups aimed at early detection and treatment of cancer and one focusing on metabolic disease: LiquidLung, HepGene and Mammogen. Incorporated in December
Medtech InsightIn May, there were two prominent acquisitions that centered on liquid biopsy technology. Labcorp agreed to pay $150m in cash for Myriad Genetics, Inc. ’s autoimmune business; while NeoGenomics, Inc.
In VivoIn May, there were two prominent acquisitions that centered on liquid biopsy technology. Labcorp agreed to pay $150m in cash for Myriad Genetics, Inc. ’s autoimmune business; while NeoGenomics, Inc.